High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.

Subjects

Subjects :

Humans
Isoniazid
Pyrazinamide
Rifampin
Tuberculosis
Tuberculosis, Multidrug-Resistant

Details

Language :

English

ISSN :

1535-4970

Volume :

201

Issue :

12

Database :

MEDLINE

Journal :

American journal of respiratory and critical care medicine

Publication Type :

Editorial & Opinion

Accession number :

32130864

Full Text :

https://doi.org/10.1164/rccm.202001-0201LE